Ligand validation:6FPJ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6FPJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FPJ_NAG_B_401	85%	58%	0.092	0.958	0.57	1.04	-	2	0	0	100%	1
6FPJ_NAG_A_402	74%	59%	0.1	0.929	0.44	1.12	-	2	0	0	100%	1
6FPJ_NAG_C_402	54%	44%	0.13	0.893	0.49	1.63	-	4	2	0	100%	1
6FPJ_NAG_A_403	53%	51%	0.131	0.891	0.52	1.34	-	2	0	0	100%	1
6FPJ_NAG_C_401	30%	65%	0.207	0.87	0.44	0.89	-	-	0	0	100%	1
6FPJ_NAG_B_403	30%	63%	0.2	0.861	0.37	1.01	-	1	0	0	100%	1
6FPJ_NAG_A_401	15%	61%	0.277	0.838	0.42	1.07	-	2	0	0	100%	1
6FPJ_NAG_B_402	11%	50%	0.234	0.753	0.69	1.22	-	2	0	0	100%	1
5FWY_NAG_D_1382	71%	60%	0.089	0.907	0.57	0.94	-	-	0	0	100%	1
3O21_NAG_A_391	67%	25%	0.09	0.898	1.71	1.33	3	3	0	0	100%	1
6FLR_NAG_A_403	24%	65%	0.203	0.842	0.38	0.96	-	1	0	0	93%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.